Dendritic cells and other innate determinants of T helper cell polarisation

Trends in Immunology

Volumn 34, Issue 11, 2013, Pages 521-530

  Walsh, Kevin P ^a   Mills, Kingston H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Adaptive immunity; CD4 T cells; Dendritic cells; Innate immunity; PAMPs; Th cell subtypes

Indexed keywords

CD209 ANTIGEN; EPITOPE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 18; INTERLEUKIN 22; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MUCIN 5AC; PATTERN RECOGNITION RECEPTOR; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 12; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; AUTOIMMUNITY; CANDIDA ALBICANS; CELL INTERACTION; CELL POPULATION; COMPLEMENT FIXATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HELPER CELL; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; INTESTINE FLORA; LANGERHANS CELL; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; NONHUMAN; POLARIZATION; REGULATORY T LYMPHOCYTE; REVIEW; SCHISTOSOMA MANSONI; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; TOXOPLASMA GONDII; TRICHINELLA SPIRALIS; TRICHURIS MURIS;

ADAPTIVE IMMUNITY; CD4 T CELLS; DENDRITIC CELLS; INNATE IMMUNITY; PAMPS; TH CELL SUBTYPES;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84886951416     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2013.07.006     Document Type: Review

References (106)

1. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
2. Litman G.W., et al. The origins of vertebrate adaptive immunity. Nat. Rev. Immunol. 2010, 10:543-553.
3. Allen J.E., Maizels R.M. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 2011, 11:375-388.
4. Mills K.H. Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 2008, 38:2636-2649.
5. Mills K.H., McGuirk P. Antigen-specific regulatory T cells - their induction and role in infection. Semin. Immunol. 2004, 16:107-117.
6. Steinman R.M., et al. Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo. J. Exp. Med. 1974, 139:1431-1445.
7. Diebold S.S. Determination of T-cell fate by dendritic cells. Immunol. Cell Biol. 2008, 86:389-397.
8. Phythian-Adams A.T., et al. CD11c depletion severely disrupts Th2 induction and development in vivo. J. Exp. Med. 2010, 207:2089-2096.
9. Akira S., et al. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
10. + T-cell responses to intestinal commensal bacteria. Nature 2013, 498:113-117.
11. 3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 2013, 210:775-788.
12. Mosmann T.R., et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348-2357.
13. + Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J. Exp. Med. 1995, 181:1285-1292.
14. Koblansky A.A., et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 2013, 38:119-130.
15. Trinchieri G., Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 2007, 7:179-190.
16. van Gisbergen K.P., et al. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J. Exp. Med. 2005, 201:1281-1292.
17. + T cells toward distinct T-helper cell subsets. Immunol. Rev. 2013, 252:12-23.
18. + T helper 1 cell differentiation. Immunity 2012, 37:1091-1103.
19. Tofukuji S., et al. Identification of a new pathway for Th1 cell development induced by cooperative stimulation with IL-4 and TGF-beta. J. Immunol. 2012, 188:4846-4857.
20. + T-cell polarization in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:9977-9982.
21. Chang J.T., et al. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta 2 subunit. Eur. J. Immunol. 2000, 30:1113-1119.
22. + T cells. Immunity 2002, 16:779-790.
23. Batten M., et al. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T Cells. J. Immunol. 2008, 180:2752-2756.
24. Hunter C.A., Kastelein R. Interleukin-27: balancing protective and pathological immunity. Immunity 2012, 37:960-969.
25. Chen F., et al. An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat. Med. 2012, 18:260-266.
26. Robinson M.W., et al. Helminth pathogen cathepsin proteases: it's a family affair. Trends Biochem. Sci. 2008, 33:601-608.
27. Sokol C.L., et al. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 2008, 9:310-318.
28. Tang H., et al. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat. Immunol. 2010, 11:608-617.
29. Everts B., et al. Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J. Exp. Med. 2012, 209:1753-1767.
30. Dillon S., et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 2004, 172:4733-4743.
31. Cervi L., et al. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J. Immunol. 2004, 172:2016-2020.
32. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 1999, 189:587-592.
33. Pulendran B., et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:1036-1041.
34. Rank M.A., et al. IL-33-activated dendritic cells induce an atypical TH2-type response. J. Allergy Clin. Immunol. 2009, 123:1047-1054.
35. Besnard A.G., et al. IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur. J. Immunol. 2011, 41:1675-1686.
36. Ito T., et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J. Exp. Med. 2005, 202:1213-1223.
37. Oh K., et al. Induction of Th2 type immunity in a mouse system reveals a novel immunoregulatory role of basophils. Blood 2007, 109:2921-2927.
38. Sullivan B.M., et al. Genetic analysis of basophil function in vivo. Nat. Immunol. 2011, 12:527-535.
39. Hammad H., et al. Inflammatory dendritic cells - not basophils - are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J. Exp. Med. 2010, 207:2097-2111.
40. Siracusa M.C., et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011, 477:229-233.
41. Giacomin P.R., et al. Thymic stromal lymphopoietin-dependent basophils promote Th2 cytokine responses following intestinal helminth infection. J. Immunol. 2012, 189:4371-4378.
42. Steinfelder S., et al. The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J. Exp. Med. 2009, 206:1681-1690.
43. Amsen D., et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 2007, 27:89-99.
44. Fang T.C., et al. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 2007, 27:100-110.
45. Kumar P., et al. Th17 cell based vaccines in mucosal immunity. Curr. Opin. Immunol. 2013, 25:373-380.
46. Cypowyj S., et al. Immunity to infection in IL-17-deficient mice and humans. Eur. J. Immunol. 2012, 42:2246-2254.
47. Rowan A.G., et al. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J. Immunol. 2008, 181:4485-4494.
48. Strasser D., et al. Syk kinase-coupled C-type lectin receptors engage protein kinase C-sigma to elicit Card9 adaptor-mediated innate immunity. Immunity 2012, 36:32-42.
49. Cua D.J., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
50. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
51. Mangan P.R., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
52. Veldhoen M., et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
53. Sutton C., et al. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1685-1691.
54. Zielinski C.E., et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012, 484:514-518.
55. Sutton C.E., et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
56. Lalor S.J., et al. Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J. Immunol. 2011, 186:5738-5748.
57. Aksentijevich I., et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N. Engl. J. Med. 2009, 360:2426-2437.
58. Gris D., et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. J. Immunol. 2010, 185:974-981.
59. Meng G., et al. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009, 30:860-874.
60. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
61. Wu H.J., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
62. Mills K.H. TLR-dependent T cell activation in autoimmunity. Nat. Rev. Immunol. 2011, 11:807-822.
63. Veldhoen M., et al. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 2009, 206:43-49.
64. Wu C., et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013, 496:513-517.
65. Sakaguchi S. Regulatory T cells in the past and for the future. Eur. J. Immunol. 2008, 38:901-937.
66. Mills K.H. Regulatory T cells: friend or foe in immunity to infection?. Nat. Rev. Immunol. 2004, 4:841-855.
67. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat. Immunol. 2005, 6:353-360.
68. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
69. McGuirk P., et al. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 2002, 195:221-231.
70. Hickey F.B., et al. Adenylate cyclase toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells. J. Leukoc. Biol. 2008, 84:234-243.
71. Dillon S., et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 2006, 116:916-928.
72. Depaolo R.W., et al. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 2008, 4:350-361.
73. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000, 192:1213-1222.
74. Bour-Jordan H., et al. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 2011, 241:180-205.
75. Manicassamy S., et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010, 329:849-853.
76. Faulkner H., et al. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur. J. Immunol. 1997, 27:2536-2540.
77. Soussi-Gounni A., et al. Role of IL-9 in the pathophysiology of allergic diseases. J. Allergy Clin. Immunol. 2001, 107:575-582.
78. Veldhoen M., et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008, 9:1341-1346.
79. - effector T cells. Nat. Immunol. 2008, 9:1347-1355.
80. Angkasekwinai P., et al. Regulation of IL-9 expression by IL-25 signaling. Nat. Immunol. 2010, 11:250-256.
81. Mielke L.A., et al. Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 2013, 210:1117-1124.
82. Sonnenberg G.F., et al. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv. Immunol. 2010, 107:1-29.
83. Zenewicz L.A., Flavell R.A. Recent advances in IL-22 biology. Int. Immunol. 2011, 23:159-163.
84. Basu R., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012, 37:1061-1075.
85. Crotty S. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 2011, 29:621-663.
86. Cannons J.L., et al. T follicular helper cell diversity and plasticity. Trends Immunol. 2013, 34:200-207.
87. Nakayamada S., et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 2011, 35:919-931.
88. + polyfunctional T cells that mediate rejection of murine tumors. Cancer Res. 2012, 72:581-591.
89. Wilkinson K.A., Wilkinson R.J. Polyfunctional T cells in human tuberculosis. Eur. J. Immunol. 2010, 40:2139-2142.
90. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740-745.
91. Ross P.J., et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 2013, 9:e1003264.
92. Rappuoli R., et al. Vaccines for the twenty-first century society. Nat. Rev. Immunol. 2011, 11:865-872.
93. Conroy H., et al. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 2008, 27:168-180.
94. Jarnicki A.G., et al. Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J. Immunol. 2008, 180:3797-3806.
95. Jones S.A., et al. Therapeutic potential of targeting IL-17. Nat. Immunol. 2012, 13:1022-1025.
96. Leonardi C.L., et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 2008, 371:1665-1674.
97. Papp K.A., et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 2008, 371:1675-1684.
98. Benn C.S., et al. A small jab - a big effect: nonspecific immunomodulation by vaccines. Trends Immunol. 2013, 10.1016/j.it.2013.04.004.
99. Nakayamada S., et al. Helper T cell diversity and plasticity. Curr. Opin. Immunol. 2012, 24:297-302.
100. Matzinger P., Kamala T. Tissue-based class control: the other side of tolerance. Nat. Rev. Immunol. 2011, 11:221-230.
101. Walker J.A., et al. Innate lymphoid cells - how did we miss them?. Nat. Rev. Immunol. 2013, 13:75-87.
102. + innate lymphoid cells. Nature 2013, 494:261-265.
103. Fuchs A., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 2013, 38:769-781.
104. Neill D.R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
105. Lee J.S., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012, 13:144-151.
106. De Luca A., et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 2010, 3:361-373.